Russell Investments Group
CGON icon

Russell Investments Group’s CG Oncology CGON Stock Holding History

Russell Investments Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
163,172
+19,826
+14% +$1.12M 0.01% 877
2025
Q4 		$5.95M Buy
143,346
+137,227
+2,243% +$5.68M 0.01% 1207
2025
Q3 		$246K Buy
6,119
+5,641
+1,180% +$164K ﹤0.01% 2733
2025
Q2 		$12.4K Buy
478
+13
+3% +$313 ﹤0.01% 3288
2025
Q1 		$11.4K Buy
465
+393
+546% +$11.1K ﹤0.01% 3215
2024
Q4 		$2.06K Sell
72
-15
-17% -$513 ﹤0.01% 3438
2024
Q3 		$3.28K Sell
87
-678
-89% -$23.8K ﹤0.01% 3297
2024
Q2 		$24.2K Buy
+765
New +$26.5K ﹤0.01% 2906

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM